Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

83 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    France Plans To Allow Biosimilar Substitution

    The French government introduced a measure that would allow pharmacists to fill prescriptions for brand-name biotech drugs with lower cost biosimilars.
    FranceFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    In-House Lawyers In France Remain Without Legal Privilege

    "Projet de loi Macron," a bill recently introduced by French Minister for Economic Affairs Emmanuel Macron, proposed the recognition of legal privilege for in-house lawyers in France.
    FranceFood, Drugs, Healthcare, Life Sciences
    Reed Smith (Worldwide)
    Reed Smith (Worldwide)
Article

French ANSM Issues Guidance On Pilot Phase Clinical Trials

The purpose of the pilot phase is to ensure that France is ready when the European Regulation comes into force.
European UnionFood, Drugs, Healthcare, Life Sciences
Jones Day
Jones Day
  • Article

    EMA Accepts Marketing Authorization Application For Alvotech's AVT06 (Aflibercept)

    On August 15, 2024, Alvotech and Advanz Pharma announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT06, Alvotech's biosimilar of low dose (2 mg)...
    FranceFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    New French Decree Clarifies The Scope Of Biomedical Research

    French Decree n° 2017-884 of May 9, 2017, was adopted to implement certain provisions of the Legal Ordinance of June 16, 2016, with respect to biomedical research.
    FranceFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    New Regulations Reshape Transparency-Related Obligations In France, Could Impact Life Sciences Companies

    In France, transparency requirements are regulated by two main sets of laws: "The French Anti-Gift Law" . . .
    FranceFood, Drugs, Healthcare, Life Sciences
    Reed Smith (Worldwide)
    Reed Smith (Worldwide)
  • Article

    The French Drug Agency Today Published 33 Decisions Imposing Fines On Pharmaceutical Companies For Alleged Non-compliance With The French Rules On Safety Stocks

    In 2021, the French drug agency determined that the stocks of hundreds of specific pharmaceutical products must be maintained by pharmaceutical companies at a level equivalent to 4 months of coverage...
    FranceFood, Drugs, Healthcare, Life Sciences
    Fieldfisher
    Fieldfisher
  • Article

    France Ramps Up Foreign Investment Regulation In The COVID-19 Era

    The European Commission recently issued COVID-19-related guidance (see Jones Day Alert, March 2020), ahead of the entry into force of the new EU FDI screening mechanism in October 2020. Several member states have been tightening ...
    FranceGovernment, Public Sector
    Jones Day
    Jones Day
  • Article

    OECD Issues Two New Test Guidelines For Nanomaterials

    The OECD has released two groundbreaking test guidelines specifically designed for nanomaterials, addressing critical gaps in standardized testing methods for dustiness determination and environmental fate assessment. These new protocols provide regulatory frameworks for measuring how nano-objects behave under various conditions, supporting decision-making processes across OECD member countries. The guidelines build upon existing OECD testing standards while introducing specialized methodologies tailored to
    FranceEnvironment
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    French Bribery Act Would Be Anti-Corruption Revolution

    We've covered the French Sunshine Act, which requires French pharmaceutical companies to disclose their links to healthcare providers, extensively over the past few years.
    FranceFood, Drugs, Healthcare, Life Sciences
    Reed Smith (Worldwide)
    Reed Smith (Worldwide)
  • Article

    Review Of A Year Of Administrative Case Law On Market Access

    After several years in which the Council of State had quashed multiple decisions on setting prices or reimbursement conditions...
    FranceFood, Drugs, Healthcare, Life Sciences
    Dechert
    Dechert
  • Article

    France Simplifies Local Medical Device Regulations And Sets Precedent For Other Member States

    On April 26, 2018, the French administrative Supreme Court (Conseil d'Etat) issued a ruling that annulled Decree 2016-1716 of December 13, 2016 ("2016 Decree") ...
    FranceFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    New French Anti-Gift Regime Finally Adopted For The Health Sector

    At long last, the new French health care anti-gift regime, modified in 2017, should be applicable as of October 1, 2020, thanks to implementing regulations adopted over the summer.
    FranceFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    The CNIL's Economic Analysis Unit Unveils Its 2026–2028 Work Programme

    In 2023, the CNIL established a dedicated service for the economic analysis of issues related to personal data, with the aim of strengthening its expertise and informing its decisions through impact assessments...
    FranceFood, Drugs, Healthcare, Life Sciences
    Delsol Avocats
    Delsol Avocats
  • Article

    The CNIL And The French National Authority For Health Join Forces To Support Digital Health Stakeholders

    The CNIL and the French National Authority for Health ("HAS") signed a partnership agreement on 10 March 2026 aimed at strengthening best practices...
    FranceFood, Drugs, Healthcare, Life Sciences
    Delsol Avocats
    Delsol Avocats
  • Article

    Non-compliance To The Interoperability, Ethics, And Security Standards May Be Penalized

    On March 4, 2026, Decree No. 2026-153 [1] ("Decree") was published, defining the procedures under which the Minister of Health may impose financial penalties on publishers of digital health services...
    FranceFood, Drugs, Healthcare, Life Sciences
    Delsol Avocats
    Delsol Avocats
  • Article

    French Sunshine Act Requires Immediate Retroactive Disclosure Of Relationships With Health Care Professionals

    The French Ministry of Health published decree no. 2013-414 on May 21 imposing transparency obligations on companies manufacturing, marketing, or providing services in relation to health and cosmetic products.
    FranceFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    French Sunshine Obligations Clarified And Extended

    The long-awaited decree that clarifies the French "Sunshine" obligations was recently published in the French Official Gazette, and it brings about some important changes...
    FranceFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    The French Sunshine Act: Towards Simplification And New Deadlines?

    Similar to the U.S. Sunshine Act, the French Sunshine Act made mandatory the publication of benefits granted by pharmaceutical laboratories to health professionals.
    FranceFood, Drugs, Healthcare, Life Sciences
    Reed Smith (Worldwide)
    Reed Smith (Worldwide)
  • Article

    French Sunshine Act Implemented…Awaiting Guidance

    As pharmaceutical and device manufacturers and others are scrambling to finalize interpretations and implementation of the U.S. Physician Payment Sunshine Act, the French government added to the activity by releasing similar transparency regulations.
    FranceFood, Drugs, Healthcare, Life Sciences
    Drinker Biddle & Reath LLP
    Drinker Biddle & Reath LLP
  • Showing 1–20 of 83 results

    Next
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics